Request Deal Involvement

Surveyor Capital led a $54m Series C round in OnKure Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Schulte Roth & Zabel

legal advisors

Schulte Roth & Zabel

Schulte Roth & Zabel

legal advisors

Schulte Roth & Zabel

Schulte Roth & Zabel

legal advisors

Schulte Roth & Zabel

or

Principals

ONKURE THERAPEUTICS

target

ONKURE THERAPEUTICS

SURVEYOR CAPITAL

bidder

SURVEYOR CAPITAL

DEEP TRACK CAPITAL

bidder

DEEP TRACK CAPITAL

ACORN BIOVENTURES

bidder

ACORN BIOVENTURES

CORMORANT ASSET MANAGEMENT

bidder

CORMORANT ASSET MANAGEMENT

PERCEPTIVE ADVISORS LLC

bidder

PERCEPTIVE ADVISORS LLC

SAMSARA BIOCAPITAL

bidder

SAMSARA BIOCAPITAL

BLACKROCK

bidder

BLACKROCK

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite